Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection

Authors:

Abstract
Overall, our studies demonstrate that proteolytic cleavage is the primary barrier to infection for a subset of zoonotic coronaviruses. Moving forward, the results argue that both receptor binding and proteolytic cleavage of the spike are critical factors that must be considered for evaluating the emergence potential and risk posed by zoonotic coronaviruses. In addition, the findings also offer a novel means to recover previously uncultivable zoonotic coronavirus strains and argue that other tissues, including the digestive tract, could be a site for future coronavirus emergence events in humans.
All Related Versions
Funding Information
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (U19AI109761)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (AI110700)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK065988)
  • United States Agency for International Development (GHN-A-OO-09-00010-00)
  • HHS | NIH | National Institute on Aging (R00AG049092)

This publication has 59 references indexed in Scilit: